zintick

Ionis Pharmaceuticals IONS

Ionis Pharmaceuticals Inc · Nasdaq · Pharmaceutical Preparations

$28.33+0.50%close on Nov. 11, 2026 · volume 6.5M · Yahoo Finance

Price, last 57 sessions

$30.00$40.00$50.00$60.00Sept. 2026Oct. 2026Nov. 2026
Aug. 24, 2026 to Nov. 11, 2026 · high $63.57 · low $28.19 · SEC filing, placed when SEC released it

Our coverage

Insider buying and selling

DateInsiderTradeSharesAvg. priceValue
Oct. 16, 2026Shannon L. Devers
EVP, Chief Human Resources Ofc
Sold1,357$43.54$59,082
Oct. 16, 2026Eric Swayze
EVP Research · indirect
Sold53$43.54$2,308
July 31, 2026Michael R. Hayden
director · indirect
Bought5,000$51.60$258,000
July 30, 2026Michael R. Hayden
director · indirect
Bought15,000$53.38$800,700

Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.

Recent SEC filings

All 16 →
  • 8-KNov. 9, 2026, 7 a.m. ETView on SEC.gov

    Results of operations and financial condition · Financial statements and exhibits

    AI summary, unreviewedIonis Pharmaceuticals Q3 2026 revenue of $243 million and GAAP EPS of -$0.66 beat consensus, but TRYNGOLZA 2026 sales guidance cut to about $50 million

  • 10-QNov. 9, 2026, 8:33 a.m. ETView on SEC.gov
  • 8-KOct. 23, 2026, 1:41 p.m. ETView on SEC.gov

    Regulation FD disclosure · Other events · Financial statements and exhibits

    AI summary, unreviewedIonis Pharmaceuticals Partner Roche Reports 43.1% Proteinuria Reduction for Sefaxersen in Phase 3 IgAN Study

  • 8-KOct. 21, 2026, 4:15 p.m. ETView on SEC.gov

    Regulation FD disclosure · Other events · Financial statements and exhibits

    AI summary, unreviewedIonis Pharmaceuticals' partner GSK wins FDA approval of Hibsago (bepirovirsen) for chronic hepatitis B, with Ionis earning royalties of 10-12% on net sales

  • 4Oct. 19, 2026, 9:40 p.m. ETView on SEC.gov
  • 4Oct. 19, 2026, 9:40 p.m. ETView on SEC.gov
  • 8-KSept. 23, 2026, 6:03 a.m. ETView on SEC.gov

    Regulation FD disclosure · Other events · Financial statements and exhibits

  • 8-KSept. 4, 2026, 5 p.m. ETView on SEC.gov

    Regulation FD disclosure · Other events · Financial statements and exhibits